Prolight Diagnostics AB (publ) (NGM:PRLD)

Market Cap	201.87M +13.6%
Revenue (ttm)	48.05M +28.6%
Net Income	-49.16M
EPS	-3.74
Shares Out	12.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,238
Open	n/a
Previous Close	16.24
Day's Range	n/a
52-Week Range	12.46 - 25.30
Beta	2.74
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Prolight Diagnostics AB

Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing systems in Sweden. The company offers Psyros, for measurement of biomarkers at extremely low concentrations; and MicroFlex, a point of care system to test with a small disposable cartridge. It also performs in-vitro diagnostic tests from a drop of blood. Prolight Diagnostics AB (publ) was incorporated in 1999 and is based in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 22
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: PRLD

Financial Performance

In 2025, Prolight Diagnostics AB's revenue was 42.20 million, an increase of 16.16% compared to the previous year's 36.33 million. Losses were -49.71 million, 84.5% more than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 15, 2026

Data Sources Report a data error